Search for a report

Reports

  • You are here:
  • Home
  • Downloads
  • EUROPE ORTHOBIOLOGICS MARKET FORECAST 2019-2027

EUROPE ORTHOBIOLOGICS MARKET FORECAST 2019-2027

The Europe market for the orthobiologics is anticipated to grow at CAGR of 5.04%. The forecast period of the orthobiologics market in the Europe region is from 2019 to 2027. The European market is termed to be the second largest market for orthobiologics market owing to the rising cases in osteoarthritis and osteoporosis.

EUROPE ORTHOBIOLOGICS MARKET FORECAST 2019-2027

Europe Orthobiologics Market by End-user (Hospitals, Orthopedic Clinics) by Products (Demineralized Bone Matrix (Dbm), Allograft, Bone Morphogenetic Protein (Bmp), Viscosupplementation, Synthetic Bone Substitutes, Stem Cell Therapy, Other Products) by Application (Spinal Fusion, Trauma Repair, Reconstructive Surgery, Tendon and Ligament, Other Applications) by Geography.

Request free sample

Report Summary

The Europe market for the orthobiologics is anticipated to grow at CAGR of 5.04%. The forecast period of the orthobiologics market in the Europe region is from 2019 to 2027. The European market is termed to be the second largest market for orthobiologics market owing to the rising cases in osteoarthritis and osteoporosis.

Also, the technological expansions in the European countries are driving the market to grow at a quicker pace, and there is a booming demand for bone graft substitutes and other biologics making a positive impact. The countries analyzed in the Europe region of the orthobiologics market are United Kingdom, France, Germany, Spain, Italy and the Rest of Europe.

 According to national health services of UK, people aging 65 years and above are at a higher risk of orthopedic disorders which is one of the fundamental driving forces of the UK Market further contributing to the market at a global scale.

However, high costs incurred coupled with poor transplant techniques is hampering the growth of the European market in the forecasting period of 2019-2027.

AAP Implantate AG, Allosource, Amedica Corporation, Baxter International Inc., Conmed Corporation, Depuy Inc. (acquired by Johnson and Johnson), Exactech Inc., Integra Lifesciences Holding Corporation, Medtronic Inc., Nuvasive Inc., RTI Surgical, Sanofi, Smith & Nephew PLC, Stryker Corporation and Zimmer Biomet Inc. are the companies mentioned in the report.

 

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    Table of Contents

    1. RESEARCH SCOPE
      • STUDY GOALS
      • SCOPE OF THE MARKET STUDY
      • WHO WILL FIND THIS REPORT USEFUL?
      • STUDY AND FORECASTING YEARS
    2. RESEARCH METHODOLOGY
      • SOURCES OF DATA
        • SECONDARY DATA
        • PRIMARY DATA
      • TOP DOWN APPROACH
      • BOTTOM-UP APPROACH
      • DATA TRIANGULATION
    3. EXECUTIVE SUMMARY
      • MARKET SUMMARY
      • KEY FINDINGS
        • HOSPITALS ARE THE LARGEST REVENUE GENERATING END-USER
        • SPINAL FUSION IS THE FASTEST GROWING APPLICATION
        • VISCOSUPPLEMENTATION HOLDS THE LARGEST MARKET SHARE IN TERMS OF PRODUCTS
    1. MARKET DYNAMICS
      • MARKET SCOPE & DEFINITION
      • MARKET DRIVERS
        • INCREASING GERIATRIC POPULATION
        • INCREASE ORTHOPAEDIC RELATED DISEASES DUE TO LIFESTYLE CHOICES
        • TECHNOLOGICAL ADVANCEMENT
      • MARKET RESTRAINTS
        • STRINGENT GOVERNMENT POLICIES
        • POST-SURGERY COMPLICATIONS
        • HIGH COST OF ORTHOPEDICS IMPLANTS
      • MARKET OPPORTUNITIES
        • INCREASED UTILIZATION OF BONE REGENERATION TECHNOLOGY
        • GROWING DISPOSABLE INCOME
        • EXPANSION OF COST EFFECTIVE MEDICAL PRODUCTS
        • HUGE MARKET OPPORTUNITIES IN DEVELOPING COUNTRIES
      • MARKET CHALLENGES
        • HIGH COST OF SPINAL FUSION SURGERY
        • POOR PERFORMANCE OF BONE GRAFT SUBSTITUTE
    1. MARKET BY END-USER
      • HOSPITALS
      • ORTHOPEDIC CLINICS
    2. MARKET BY PRODUCTS
      • DEMINERALIZED BONE MATRIX (DBM)
      • ALLOGRAFT
      • BONE MORPHOGENETIC PROTEIN (BMP)
      • VISCOSUPPLEMENTATION
      • SYNTHETIC BONE SUBSTITUTES
      • STEM CELL THERAPY
      • OTHER PRODUCTS
    3. MARKET BY APPLICATION
      • SPINAL FUSION
      • TRAUMA REPAIR
      • RECONSTRUCTIVE SURGERY
      • TENDON AND LIGAMENT
      • OTHER APPLICATIONS
    4. KEY ANALYTICS
      • PORTER’S FIVE FORCE MODEL
        • THREAT OF NEW ENTRANTS
        • THREAT OF SUBSTITUTE
        • BARGAINING POWER OF BUYER
        • BARGAINING POWER OF SUPPLIER
        • INTENSITY OF COMPETITIVE RIVALRY
      • PESTEL ANALYSIS
      • PATENT ANALYSIS
      • KEY BUYING CRITERIA
      • VALUE CHAIN ANALYSIS
      • OPPORTUNITY MATRIX
    5. GEOGRAPHICAL ANALYSIS
      • EUROPE
        • THE UNITED KINGDOM
        • FRANCE
        • GERMANY
        • SPAIN
        • ITALY
        • REST OF EUROPE
    1. COMPETITIVE LANDSCAPE
      • MARKET SHARE ANALYSIS
      • COMPANY PROFILES
        • AAP IMPLANTATE AG
          • COMPANY OVERVIEW
          • PRODUCT PORTFOLIO
          • SCOT ANALYSIS
        • ALLOSOURCE
          • COMPANY OVERVIEW
          • PRODUCT PORTFOLIO
          • SCOT ANALYSIS
          • STRATEGIC INITIATIVE
        • AMEDICA CORPORATION
          • COMPANY OVERVIEW
          • PRODUCT PORTFOLIO
          • SCOT ANALYSIS
          • STRATEGIC INITIATIVES
        • BAXTER INTERNATIONAL INC.
          • MARKET OVERVIEW
          • PRODUCT PORTFOLIO
          • SCOT ANALYSIS
          • STRATEGIC INITIATIVES
        • CONMED CORPORATION
          • COMPANY OVERVIEW
          • PRODUCT PORTFOLIO
        • DEPUY INC. (ACQUIRED BY JOHNSON AND JOHNSON)
          • COMPANY OVERVIEW
          • PRODUCT PORTFOLIO
          • SCOT ANALYSIS
          • STRATEGIC INITIATIVES
        • EXACTECH INC.
          • COMPANY OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
        • INTEGRA LIFESCIENCES HOLDING CORPORATION
          • COMPANY OVERVIEW
          • PRODUCT PORTFOLIO
          • SCOT ANALYSIS
          • STRATEGIC INITIATIVES
        • MEDTRONIC INC.
          • COMPANY OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
        • NUVASIVE INC.
          • COMPANY OVERVIEW
          • PRODUCT PORTFOLIO
          • SCOT ANALYSIS
          • STRATEGIC INITIATIVES
        • RTI SURGICAL
          • COMPANY OVERVIEW
          • PRODUCT PORTFOLIO
          • SCOT ANALYSIS
          • STRATEGIC INITIATIVES
        • SANOFI
          • COMPANY OVERVIEW
          • PRODUCT PORTFOLIO
          • SCOT ANALYSIS
          • STRATEGIC INITIATIVES
        • SMITH & NEPHEW PLC
          • COMPANY OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
        • STRYKER CORPORATION
          • COMPANY OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
        • ZIMMER BIOMET INC.
          • COMPANY OVERVIEW
          • PRODUCT PORTFOLIO
          • SCOT ANALYSIS
          • STRATEGIC INITIATIVES

     

    TABLE LIST

    TABLE  1       EUROPE ORTHOBIOLOGICS MARKET 2019-2027 ($ MILLION)

    TABLE  2       POST-SURGERY COMPLICATION

    TABLE  3       EUROPE ORTHOBIOLOGICS MARKET BY END-USER 2019-2027 ($ MILLION)

    TABLE  4       EUROPE HOSPITALS MARKET 2019-2027 ($ MILLION)

    TABLE  5       EUROPE ORTHOPEDIC CLINICS MARKET 2019-2027 ($ MILLION)

    TABLE  6       EUROPE ORTHOBIOLOGICS MARKET BY PRODUCTS 2019-2027 ($ MILLION)

    TABLE  7       EUROPE DEMINERALIZED BONE MATRIX (DBM) MARKET 2019-2027 ($ MILLION)

    TABLE  8       EUROPE ALLOGRAFT MARKET 2019-2027 ($ MILLION)

    TABLE  9       EUROPE BONE MORPHOGENETIC PROTEIN (BMP) MARKET 2019-2027 ($ MILLION)

    TABLE  10     EUROPE VISCOSUPPLEMENTATION MARKET 2019-2027 ($ MILLION)

    TABLE  11     EUROPE SYNTHETIC BONE SUBSTITUTES MARKET 2019-2027 ($ MILLION)

    TABLE  12     EUROPE STEM CELL THERAPY MARKET 2019-2027 ($ MILLION)

    TABLE  13     EUROPE OTHER PRODUCTS MARKET 2019-2027 ($ MILLION)

    TABLE  14     EUROPE ORTHOBIOLOGICS MARKET BY APPLICATION 2019-2027 ($ MILLION)

    TABLE  15     EUROPE SPINAL FUSION MARKET 2019-2027 ($ MILLION)

    TABLE  16     EUROPE TRAUMA REPAIR MARKET 2019-2027 ($ MILLION)

    TABLE  17     EUROPE RECONSTRUCTIVE SURGERY MARKET 2019-2027 ($ MILLION)

    TABLE  18     EUROPE TENDON AND LIGAMENT MARKET 2019-2027 ($ MILLION)

    TABLE  19     EUROPE OTHER APPLICATIONS MARKET 2019-2027 ($ MILLION)

    TABLE  20     EUROPE ORTHOBIOLOGICS MARKET BY COUNTRY 2019-2027 ($ MILLION)

    TABLE  21     AGE STRUCTURE OF GERMANY 2017

    FIGURES LIST

    FIGURE  1     EUROPE ORTHOBIOLOGICS MARKET 2019-2027 ($ MILLION)

    FIGURE  2     INCREASING DEMAND OF MINIMAL INVASIVE TECHNOLOGIES 2010-2025 ($ MILLION)

    FIGURE  3     EUROPE ORTHOBIOLOGICS MARKET SHARE BY END USER 2018 & 2027 (%)

    FIGURE  4     EUROPE ORTHOBIOLOGICS MARKET BY HOSPITALS 2019-2027 ($ MILLION)

    FIGURE  5     EUROPE ORTHOBIOLOGICS MARKET BY ORTHOPEDIC CLINICS 2019-2027 ($ MILLION)

    FIGURE  6     EUROPE ORTHOBIOLOGICS MARKET SHARE BY PRODUCTS 2018 & 2027 (%)

    FIGURE  7     EUROPE ORTHOBIOLOGICS MARKET BY DEMINERALIZED BONE MATRIX (DBM) 2019-2027 ($ MILLION)

    FIGURE  8     EUROPE ORTHOBIOLOGICS MARKET BY ALLOGRAFT 2019-2027 ($ MILLION)

    FIGURE  9     EUROPE ORTHOBIOLOGICS MARKET BY BONE MORPHOGENETIC PROTEIN (BMP) 2019-2027 ($ MILLION)

    FIGURE  10  EUROPE ORTHOBIOLOGICS MARKET BY VISCOSUPPLEMENTATION 2019-2027 ($ MILLION)

    FIGURE  11  EUROPE ORTHOBIOLOGICS MARKET BY SYNTHETIC BONE SUBSTITUTES 2019-2027 ($ MILLION)

    FIGURE  12  EUROPE ORTHOBIOLOGICS MARKET BY STEM CELL THERAPY 2019-2027 ($ MILLION)

    FIGURE  13  EUROPE ORTHOBIOLOGICS MARKET BY OTHER PRODUCTS 2019-2027 ($ MILLION)

    FIGURE  14  EUROPE ORTHOBIOLOGICS MARKET SHARE BY APPLICATION 2018 & 2027 (%)

    FIGURE  15  EUROPE ORTHOBIOLOGICS MARKET BY SPINAL FUSION 2019-2027 ($ MILLION)

    FIGURE  16  EUROPE ORTHOBIOLOGICS MARKET BY TRAUMA REPAIR 2019-2027 ($ MILLION)

     

    FIGURE  17  EUROPE ORTHOBIOLOGICS MARKET BY RECONSTRUCTIVE SURGERY 2019-2027 ($ MILLION)

    FIGURE  18  EUROPE ORTHOBIOLOGICS MARKET BY TENDON AND LIGAMENT 2019-2027 ($ MILLION)

    FIGURE  19  EUROPE ORTHOBIOLOGICS MARKET BY OTHER APPLICATIONS 2019-2027 ($ MILLION)

    FIGURE  20  PORTER’S FIVE FORCE MODEL

    FIGURE  21  EUROPE ORTHOBIOLOGICS MARKET REGIONAL OUTLOOK 2018 & 2027 (%)

    FIGURE  22  EUROPE ORTHOBIOLOGICS MARKET BY COUNTRY 2018  & 2027

    FIGURE  23  THE UNITED KINGDOM ORTHOBIOLOGICS MARKET 2019-2027 ($ MILLION)

    FIGURE  24  FRANCE ORTHOBIOLOGICS MARKET 2019-2027 ($ MILLION)

    FIGURE  25  GERMANY ORTHOBIOLOGICS MARKET 2019-2027 ($ MILLION)

    FIGURE  26  SPAIN ORTHOBIOLOGICS MARKET, 2019-2027 ($ MILLION)

    FIGURE  27  ITALY ORTHOBIOLOGICS MARKET, 2019-2027 ($ MILLION)

    FIGURE  28  REST OF EUROPE ORTHOBIOLOGICS MARKET 2019-2027 ($ MILLION)

    FIGURE  29  ORTHOBIOLOGICS COMPANY  MARKET SHARE 2018 (% )

    Segmentation

    1. GEOGRAPHICAL ANALYSIS
      • EUROPE
        • THE UNITED KINGDOM
        • FRANCE
        • GERMANY
        • SPAIN
        • ITALY
        • REST OF EUROPE
    1. MARKET BY END USER
      • HOSPITALS
      • ORTHOPEDIC CLINICS
    2. MARKET BY PRODUCTS
      • DEMINERALIZED BONE MATRIX (DBM)
      • ALLOGRAFT
      • BONE MORPHOGENETIC PROTEIN (BMP)
      • VISCOSUPPLEMENTATION
      • SYNTHETIC BONE SUBSTITUTES
      • STEM CELL THERAPY
      • OTHER PRODUCTS
    3. MARKET BY APPLICATION
      • SPINAL FUSION
      • TRAUMA REPAIR
      • RECONSTRUCTIVE SURGERY
      • TENDON AND LIGAMENT
      • OTHER APPLICATIONS

    Request Free Sample

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      RELATED REPORTS

      Author: shalini amarnani